The Second Hospital of Hebei Medical University | China
Dr. Huang is a distinguished researcher and attending physician specializing in perioperative neuroscience, with a Ph.D. in anesthesiology from Hebei Medical University. His career has centered on elucidating the molecular pathways through which blood–brain barrier dysfunction contributes to neurocognitive decline in aging surgical populations. Integrating molecular biology, neuroimaging, immunology, and microbiome science, he has established a multidisciplinary research program that advances understanding of the vascular–immune mechanisms driving perioperative neurocognitive disorders. From anesthesia-induced neurotoxicity in early studies to complex “vascular-immune–microbiome” interactions in recent work, his contributions span preclinical models, translational investigations, and clinical cohort studies. He has served as principal investigator on more than ten major funded projects, including multiple National Natural Science Foundation of China grants, and has earned notable distinctions such as the Hebei Province Science and Technology Progress Award and several first-prize Hebei Medical Science Awards. His commitment to academic scholarship includes translating Miller’s Anesthesia, editing national textbooks, and co-authoring expert consensus guidelines that shape anesthesiology education and practice nationwide. With a portfolio of influential publications and six national patents in airway-management innovations, Dr. Huang continues to advance therapeutic development and scientific knowledge in surgical brain protection and perioperative cognitive health.
Featured Publications
SPP1-mediated crosstalk between macrophages and fibroblasts promotes benign airway stenosis. (2025). Archives of Biochemistry and Biophysics.
Association between preoperative blood–brain barrier permeability and postoperative delirium in older patients undergoing cardiac surgery: a pilot study. (2025). Aging Clinical and Experimental Research.
Central neuropeptides as key modulators of astrocyte function in neurodegenerative and neuropsychiatric disorders. (2025).
Neonatal sevoflurane exposure disrupted fatty acids metabolism, leading to hypomyelination and neurological impairments. (2025). Biomedicine and Pharmacotherapy.